摘要
卵巢恶性生殖细胞肿瘤(MOGCTs)发病仅次于上皮性肿瘤,多发生于年轻的妇女及幼女,恶性程度高,死亡率高。有效的治疗在临床上尤为重要。近年来,由于找到有效的化疗方案,使其预后大为改观。手术治疗在MOGCTs(卵巢恶性生殖细胞肿瘤)的初次治疗及再次治疗中仍然发挥着重要的作用。二十世纪七十年代起,全面分期手术(CSS)使卵巢恶性生殖细胞肿瘤患者的预后得到改善。腹膜后淋巴结的切除是卵巢恶性肿瘤标准全面分期手术的一个组成部分,本文就卵巢恶性生殖细胞肿瘤行全面分期手术的临床意义从多方面进行探讨。
Malignant ovariangerm cell tumors (MOGCTs) is second only to epithelial tumor which often occur in young women and young women, with high malignancy and high mortality. Effective treatment is particularly important in clinical practice. The prognosis is improved for valid chemotherapy scheme founded in recent years. Surgery still play a crucial role in the therapy of MOGCTs no matter for the primary op- eration or re-operation. Since the 70s, the comprehensive surgical staging (CSS) has improved the prognosis in patients with malignant ovarian cell tumors. Retroperitoneal lymphadenectomy is an integral part of the complete staging in MOGCT. The paper discusses various aspects of the clinical value of comprehensive surgical staging in MOGCTs.
作者
黄巧丽
陈亦乐
陈笑
许向宁
袁礼
Huang Qiaoli;Chen Yile;Chen Xiao;Xu Xiangning;Yuan Li(Department of Gynaecological Oncology , Hunan Cancer Hospital, Changsha 410013, China;Department of Gynaecological Oncology , Changsha Kexin Cancer Hospital, Changsha 410013, China)
出处
《中国医师杂志》
CAS
2018年第4期638-640,F0003,共4页
Journal of Chinese Physician